T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica release_b5wfdr7ztvhu3aqfj5bpr65j7i

by Giulia Ceglie, Laura Papetti, Lorenzo Figà Talamanca, Barbarella Lucarelli, Mattia Algeri, Stefania Gaspari, Giuseppina Li Pira, Giovanna‐Stefania Colafati, Mauro Montanari, Massimiliano Valeriani, Franco Locatelli, Pietro Merli

Published in Annals of Clinical and Translational Neurology by Wiley.

2019   Volume 6, Issue 10, p2110-2113

Abstract

Neuromyelitis optica is an immune-mediated disease characterized by a relapsing course, resulting in progressive disability. In children, given the long life expectancy, a disease-modifying treatment could be particularly desirable. Unfortunately, the currently available treatment strategies with this potential are scarce. Very limited data are available about the use of allogeneic hematopoietic stem cell transplantation (HSCT) for autoimmune neurological diseases. In this report, we present a pediatric case successfully treated with allogeneic HSCT from an HLA-haploidentical donor, after ex vivo TCR/CD19-depletion of the graft. To the best of our knowledge, this is the first case of a pediatric patient to benefit from such a treatment.
In text/plain format

Archived Files and Locations

application/pdf  373.8 kB
file_d5zklpqfl5arfbqjw2adus4hcm
europepmc.org (repository)
web.archive.org (webarchive)
application/pdf  363.6 kB
file_keabjk4cwnefxlbvoveg2qyp6i
iris.uniroma1.it (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-09-17
Language   en ?
DOI  10.1002/acn3.50843
PubMed  31529689
PMC  PMC6801170
Container Metadata
Open Access Publication
In DOAJ
In Keepers Registry
ISSN-L:  2328-9503
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: fea22c71-7fbf-4475-93f1-31aa64bab09f
API URL: JSON